Buy & Sell Deere & Company (DE) – Deere & Company Price Today
Aura AI Summary
Key Stats
- $155.34BMarket Cap
- IndustrialsSector
- -14.38%3M Drawdown
- $210.17BEnterprise Value
- 1.13%Dividend Yield
- 0% Buy | 100% SellTrading Activity
- 76 daysTypical Hold Time
Deere & Company (DE) is currently valued at a market capitalization of $155.34B, with an enterprise value of $210.17B. Over the past 52 weeks, Deere & Company has traded between a low of $439.11 and a high of $662.49, highlighting its annual price range. Over the past three months, Deere & Company has recorded a drawdown of -14.38%, reflecting recent price volatility. Deere & Company offers a dividend yield of 1.13%, with the most recent dividend of $1.62 paid on 31 Mar 26. On average, investors hold Deere & Company for approximately 76 days, indicating typical investor behavior on the platform.
About Deere & Company
Deere is the world's leading manufacturer of agricultural equipment, producing some of the most recognizable machines in the heavy machinery industry. The company is divided into four reportable segments: production and precision agriculture, small agriculture and turf, construction and forestry, and John Deere Capital. Its products are available through an extensive dealer network, which includes over 1,900 dealer locations in North America and approximately 3,700 locations globally. John Deere Capital provides retail financing for machinery to its customers, in addition to wholesale financing for dealers, which increases the likelihood of Deere product sales.
Most Recent News
Defiance ETFs launches SPCQ, a 2x inverse leveraged ETF targeting daily SpaceX stock declines.
Defiance ETFs introduced the Defiance Daily Target 2X Short SpaceX ETF (SPCQ), designed to provide investors with double inverse exposure to SpaceX's daily stock price movements. This ETF aims to deliver -200% of SpaceX's daily returns, allowing inve...

Halper Sadeh LLC probes fairness of recent major company sales and mergers for shareholders.
Halper Sadeh LLC, an investor rights law firm, is investigating whether shareholders of Open Lending Corporation, Nuvalent, Organon & Co., and SUNation Energy are receiving fair deals in their companies' recent sales or mergers. The firm suggests ins...

Global GLP-1 receptor agonist market to reach $95.3B by 2035, growing at 12.1% CAGR driven by diabetes and obesity demand.
The global GLP-1 receptor agonist market, used primarily for type 2 diabetes and obesity management, is projected to grow from $28.7 billion in 2025 to $95.3 billion by 2035, at a compound annual growth rate of 12.1%. Growth is fueled by rising diabe...
